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Abstract Parietaria judaica pollen is a common
cause of airway allergic disease in the Mediterranean
area. Proteome analysis of mature Parietaria judaica
pollen by two-dimensional gel electrophoresis (2-DE)
and mass spectrometry has established the first
reference proteome map of this weed. Proteins
involved in a variety of cellular functions as well as
the occurrence of allergens were detected. By using
2-DE and immunoblotting with sera from Parietaria
judaica allergic patients we obtained a more detailed
characterization of Parietaria judaica allergen profile
so to improve our comprehension of the pathogenesis
of pollen-induced allergic reaction.
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Introduction
Parietaria judaica belongs to the Urticaceae family
and is commonly found in urban and rural areas.
Its pollen is one of the main causes of allergy in the
Mediterranean area (Masullo et al. 1996). Parietaria
judaica pollen allergens have been identified and
characterized by immunochemical and molecular-bio-
logical techniques (Amoresano et al. 2003; Stumvoll
et al. 2003). Par j 1 and Par j 2 represent two major
allergens belonging to a family of glycoproteins known
as non-specific lipid transfer proteins (Salcedo et al.
2004). Recently, the presence of minor allergens like
profilin (Par j 3) and 2-EF-hand (Par j 4) proteins have
been also described (Asturias et al. 2004; Bonura et al.
2008). However, other proteins, specific isoforms or
post-translational modifications (PTM) of known aller-
gens, can contribute to hypersensitivity reactions in
allergic individuals. The accurate diagnosis of hyper-
sensitive patients as well as the in-deep knowledge of
the mixtures for a effective immunotherapy depend on
the molecular characterization of all allergenic compo-
nents from a biological source.
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Proteomic profiling of pollen extracts coupled
with classical immunological approaches have been
applied to examine the presence of novel allergenic
components in maize, grass, and other species (Gon-
za´lez-Buitrago et al. 2007; Petersen et al. 2006). An
understanding of P. judaica pollen proteome would
provide insight in the molecular nature of allergens as
well as of other proteins involved in the functional
specialization of pollen. Using 2-DE followed by
LC-MS/MS analyses, we generated the first reference
map of the P. judaica mature pollen proteome. In total,
we identified 70 protein spots including isoforms, and
by using an immunoproteomic approach with serum
from P. judaica allergic patients, we have obtained a
more detailed characterization of Parietaria judaica
allergen profile so to improve our comprehension of
the molecular determinants of P. judaica-induced
allergic reaction. In particular, we have evidenced that
the IgE from patients recognise Par j 1 and the Par j 2
P2 allergens while they don’t recognise the polypep-
tide Par j 2 P8. These results could provide important
indications to develop new and more efficient vaccines
for allergic patients.
Materials and methods
Pollen collection and protein extraction
Pollen from Parietaria judaica was purchased from
Allergon (A¨ngelholm, Sweden) and extracted as
previously described (Alessandro et al. 2009).
Briefly, the pollen grains were defatted with diethyl
ether, extracted in PBS at 4C, dialysed against water
and finally lyophilised and stored at -80C until use.
2-DE, image acquisition and analysis
Aliquots of the lyophilised proteins, 60 lg for
analytical gels and 1 mg for preparative gels, were
solubilized in a buffer containing 8 M urea, 4% w/v
CHAPS, 40 mM Tris and 65 mM DTE and a trace
amount of Bromophenol Blue.
The first dimension IEF was carried out using
immobilized pH gradient (IPG) strips, pH 3–10 non-
linear and pH 4–9 linear, 18 cm long. The first dimension,
equilibration steps and the second dimension were
performed as previously described (Fontana et al. 2007).
Gels were stained with ammoniacal silver nitrate
for analytical gels (Hochstrasser et al. 1988) or
Comassie staining for preparative gels. The gels were
scanned by densitometer ImageScanner II (GE
Healthcare Life Science, NJ, USA) and the Image-
Master 2D Platinum 6.0 software (GE Healthcare
Life Science, NJ, USA) was used to perform the
qualitative and quantitative analysis of the 2-DE
maps. Human serum was used as internal standard for
isoelectric point (pI) and Molecular Weight (MW)
calibration of the 2-DE gel with pH 3–10 non linear
gradient (Bjellqvist et al. 1993).
In-gel protein digestion
Coomassie Blue or silver-stained protein spots were
excised from the preparative gels and cut into 1-mm
pieces. In-gel digestion was performed as described
by Shevchenko et al. (1996) with minor modifica-
tions. De-staining was obtained by successive washes
with 20 mM NH4HCO3 buffer and H2O/acetonitrile
(50/50 v/v) mixture for Coomassie Blue. For prote-
olytic digestion, the gel was treated by 5–15 ll
trypsin (20 ng/ll in 50 mM NH4HCO3) for 5 h at
37C. The resulting tryptic peptides were extracted
from the gel by centrifugation and the supernatant
fraction was recovered. A second extraction step was
performed using 10–15 ll H2O/acetonitrile/formic
acid (60/36/4; by vol.) for 30 min and, finally, all
extracts were pooled. For LC-ESI/MS/MS experi-
ments, extracts were dried under vacuum and
re-suspended in 0.1% TFA solution.
NanoLC/nanospray/tandem mass spectrometry
(LC-ESI/MS/MS)
Experiments were performed on a Q-STAR XL
instrument (Applied Biosystems, Courtaboeuf, France)
equipped with a nanospray source using a distal coated
silica-tip emitter (FS 150-20-10-D-20, New Objective,
USA) set at 2300 V. Information Dependent Acquisi-
tion (IDA) mode allowed ?2 to ?4 charged peptide
ions within a m/z 400–2000 survey scan mass range to
be analyzed for subsequent fragmentation. MS/MS
spectra were acquired in the m/z 65–2000 range. The
collision energy was automatically set by the software
(Analyst 1.0) and was related to the charge of the
precursor ion. The MS and MS/MS data were recal-
ibrated using internal reference ions from a trypsin
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autolysis peptide at m/z 842.510 [M ? H]? and m/z
421.759 [M?2H]2?. Deconvolution of the TOF MS
spectra were done with Bayesian Peptide Reconstruct
tool of Analyst. Multicharged ions in 700–1,800 m/z
range with 0.2 Da mass tolerance were used to
calculate glycopeptide masses from 2,000 to 4,000 Da.
Tryptic peptides were separated using an Ultimate-
nanoLC (Dionex, Voisins Le Bretonneux, France)
with a C18 PepMap micro-precolumn (5 lm; 100 A˚
´
;
300 lm 9 5 mm; Dionex) and a C18 PepMap nano-
column (3 lm; 100 A˚´ ; 75 lm 9 150 mm; Dionex).
After a 3 min wash with 0.05% TFA in H2O/
acetonitrile (98/2 v/v) of the injected sample solution
on the micro-precolumn, the chromatographic sepa-
ration was developed using a linear 60 min gradient
from 0 to 50% B, where solvent A was 0.1% formic
acid in H2O/acetonitrile (95/5 v/v) and solvent B was
0.08% formic acid in H2O/acetonitrile (20/80 v/v) at
approx 200 nl/min.
Protein identifications were performed using the
Paragon Algorithm thorough search mode in Protein-
PilotTM software (Applied Biosystems, Courtaboeuf,
France).
Patient sera
For the identification of IgE-reactive proteins, sera
from patients (n = 10) sensitized to Parietaria
judaica whose radio-allergosorbent test (RAST)
exhibited scores over 3, were used. Control sera
were from healthy, non-allergic subjects and from
subjects sensitized to other allergic sources (dust
mite, Olea and Cupressus). All sera were stored at
-80C until use.
Immunoblotting
For immunoblot analysis, 2-DE gel was transferred to
nitrocellulose membrane (Hybond-ECL, Amersham
Bioscience, Little Chalfont, UK) and the membrane
was incubated in blocking solution (5% w/v non-fat
dry milk, 20 mM Tris, 140 mM NaCl, 0.1% Tween
20) (TBST) at room temperature. After several
washings in TBST buffer, the filters were incubated
overnight at room temperature with sera from allergic
patients diluted 1:10 followed by horseradish perox-
idase (HRP)-conjugated rabbit anti human IgE
(1:2,000 dilution). After washings in TBST buffer,
immunocomplexes were detected by the enhanced
chemiluminescence detection system (Super Signal,
Pierce, Rockford, IL, USA).
Results and discussion
Proteome map of Parietaria judaica pollen
Parietaria judaica represents the main cause of
allergy in the Mediterranean area where up to 80%
of pollinosis patients are sensitized against the
proteins composing the P. judaica pollen. With the
aim of obtaining a comprehensive and detailed
analysis of Parietaria judaica pollen content, we
extracted total protein from 1.5 g mature pollen.
Aliquots of the protein samples were subjected to
2-DE analysis and representative silver-stained 2D
gel is shown in Fig. 1. Good reproducibility and
resolution were achieved throughout the experimental
procedures. On average 975 protein spots were
clearly resolved using IPG strips pH 3–10 non-linear.
Protein identification
To obtain a first reference proteomic map of the
pollen, 100 protein spots were excised from Coo-
massie Blue-stained gels and among these, 70 protein
spots (corresponding to 21 different proteins) were
identified by LC-MS/MS technology (Supplementary
Table 1). Identified proteins ranged in calculated
molecular mass from 92 to 7.5 kDa and in calculated
pI from 4.3 to 7.1. All proteins were designated with
arbitrary spot numbers as shown in Fig. 1. While the
identification of proteins by proteomics methodology
has found extensive application with organisms
which have a complete sequence of their genomes
already available, cross species identification has
been used to identify proteins from several plant
species (Faulkner et al. 2005; Fernando 2005; Wang,
et al. 2005). In fact, in our work, due to the poor
protein and DNA sequence database coverage in
Parietaria judaica (only 7 proteins are present in
Uni-Prot database for this plant), MS analyses
allowed the recognition of 25 protein spots from P.j
and 45 from other species (Supplementary Table 1).
Multiple spots corresponding to the same protein
were also identified, as described in other proteomic
studies, and reasonably corresponding to post-
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translational modifications, protein degradation, dif-
ferent isoforms derived from different genes of a
multigene family or products of alternatively spliced
mRNAs.
Figure 2 shows the distribution of P.j pollen
proteins according to their functional classification.
Briefly, the proteins were grouped in four distinct
functional classes: proteins involved in carbon metab-
olism and energy generation, cytoskeletal and calcium-
binding proteins, stress-related proteins, pollen
allergens and proteins involved in the methionine
metabolism. With respect to specific allergens, we
identified 11 spots (37–47) corresponding to Par j 2 P2
protein, 13 spots (49–61) corresponding to Par j 2 P8
protein, while 1 spot (36) corresponded to Par j 1 P1
protein. A search of Par j 1 and 2 protein sequences,
using specific softwares supported by ExPaSy Proteo-
mics Server evidenced both O-glycosylation sites and
phosphorylation sites (http://ogpet.utep.edu/OGPET,
http://www.cbs.dtu.dk/services/NetPhos).
In particular, Par j 1 P1 protein has one glycosyl-
ation sites and five phosphorylation sites, Par j 2 P8
protein has five phosphorylation sites and Par j 2 P2
protein has three phosphorylation sites. These post-
translational modifications do not change signifi-
cantly the molecular weight of a protein but they may
Fig. 1 Representative
proteomic map of
Parietaria judaica pollen,
proteins (60 lg) were
loaded on IPG strips
(18 cm, 3.5–10 non-linear
pH). The second dimension
was performed on a vertical
linear-gradient slab gel
(9–16%). Gel was silver
stained
Fig. 2 Pie-chart representing the percentage distribution of
identified pollen proteins within functional classes
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be responsible of the shifts in isoelectric points. At
the same time, post-translational modifications might
have an influence on the Ig binding so that the
knowledge of the structure of allergens is important
to improve diagnosis and therapy of allergy (Ferreira
et al. 2006).
Identification of IgE reactive spots by 2-DE
and pollen allergens
Although molecular biology and immunological
methodologies have allowed the identification of
Par j 1 and Par j 2 as the major pollen components
responsible of allergic reaction and profilin as a
minor allergen (Asturias et al. 2007), the study of P.j
pollen allergens have never been completed by using
an immunoproteomic approach. Since Par j 1 and
Par j 2 are basic proteins, to improve the separation
of their several isoforms, the pollen protein samples
were run on IPG strips 6–9 linear, which allows a
better separation of polypeptides with a pI higher
than 7. Figure 3a shows a representative Coomassie-
stained 2 D gels and corresponding immunoblot
obtained by using pooled sera of allergic patients
(Fig. 3b). In order to better characterize the biochem-
ical identities of immunoreactive spots (Fig. 3a,
numbers 1–7) they were excised from Coomassie-
stained 2-DE gel and subjected to LC-ESI MS/MS.
Table 2 in Supplementary Material shows the results
of protein spot identifications. Protein spots numbers
1 and 2 are isoforms of Par j 1 allergen, protein spots
numbers 3–5 are isoforms of Par j 2 P8 while protein
spots 6 and 7 are isoforms of Par j 2 P2 allergen.
Figure 3b, shows a representative western blot using
the pooled sera from patients. In particular, the spot
indicated with arrows corresponds to Par j 1 and spot
included in the square corresponds to Par j 2 P2.
Control experiments, carried out with pooled sera
from 10 nonsensitized subject, indicated the speci-
ficity of antibody detection (Fig. 3c). Interestingly,
no reaction was ever observed against Par j 2 P8
suggesting that Par j 2 P2, together with Par j 1, are
the main allergenic components present in Parietaria
judaica pollen.
The data presented in our study show for the first
time the identification of Parietaria judaica pollen
allergens through bidimensional western blot thus
representing satisfactory tools for immunological
characterization and classification of the proteins
from a raw plant extract.
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